School of Medicine researchers have received $29 million from the National Institute on Aging of the National Institutes of Health to continue a long-running, international Alzheimer’s study aimed at understanding how the disease develops and progresses.
A new study from the School of Medicine suggests that bone marrow — or blood stem cells — from healthy donors can harbor extremely rare mutations that can cause health problems for the cancer patients who receive them. Such stem cell transplants are important for treating blood cancers, including acute myeloid leukemia.
Tammy Matuska, a clinical nurse coordinator in the Division of Hematology & Oncology at Washington University School of Medicine in St. Louis, has been named a 2019 MPN Hero by CURE magazine, a national publication for cancer patients and their caregivers.
Exposure to chemotherapy and radiation during cancer treatment leads to bone loss and increases the risk of osteoporosis and fractures. A new School of Medicine study identifies the trigger for this bone loss and suggests ways to prevent it.
Washington University’s Jerome Cox and Jack H. Ladenson join a small but distinguished group of fellows of the National Academy of Inventors, the highest professional distinction accorded solely to academic inventors.
Taevin Symone Lewis, a recent graduate of the Program in Occupational Therapy at the School of Medicine, died Jan. 1 in a motor vehicle accident in St. Louis. She was 26. A funeral service will take place Saturday, Jan. 11, in Memphis, Tenn.
R. Edward Hogan, MD, professor of neurology and head of the Adult Epilepsy Section at Washington University School of Medicine in St. Louis, has been elected second vice president of the American Epilepsy Society. In 2022, he will become the organization’s president.
Two students at Washington University School of Medicine in St. Louis have been named top young entrepreneurs by Forbes magazine.
A new study, led by the Washington University School of Medicine in St. Louis and the Perelman School of Medicine at the University of Pennsylvania, suggests proton therapy is as effective as traditional X-ray radiation therapy while causing fewer serious side effects.
A study from the School of Medicine may help explain why previous attempts to develop a staph vaccine have failed, while also suggesting a new approach to vaccine design that focuses on activating an untapped set of immune cells.